Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-25 | New | $30,100,000 | $30,100,000 | Equity Only | 06b | SEC link |
| 2024-07-02 | New | $11,800,000 | $11,800,000 | Equity Only | 06b | SEC link |
| 2023-06-27 | New | $37,536,853 | $37,536,853 | Equity Only | 06b | SEC link |
| 2023-04-18 | New | $750,000 | $750,000 | Equity Only | 06b | SEC link |
| 2021-10-06 | New | $29,999,995 | $29,999,995 | Equity Only | 06b | SEC link |
| 2018-04-17 | New | $200,870 | $200,870 | Equity Only | 06b | SEC link |
| 2007-05-16 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Harry W. Alcorn Jr. | Executive |
| Amy L. Burroughs | Director |
| Dominic Cundari | Executive |
| Julie Daves | Executive |
| Sydney Gilman | Executive |
| Michael R. Giuffre | Director |
| R. Michael Giuffre | Director |
| Kirsten Gruis | Executive |
| David Gurvey | Executive |
| Scott Kellen | Executive |
| Richard Kuntz | Director |
| Tanya N. Lewis | Director |
| Lorianne Masuoka | Executive |
| Daniel O'connor | Director |
| Paul Papi | Executive |
| James T. Parsons | Director |
| Rick Pauls | Director, Executive |
| Richard D. Pilnik | Director |
| Charles P. Semba | Director |
| Todd Verdoorn | Executive |
| David J. Wambeke | Executive |
| Zhenyu (Jerry) Xiao | Director |